Skip to content

Pacific Perspectives

‘Significant risk’ Australian inflation might stop falling: IMF

The International Monetary Fund has warned of a significant risk that inflation will stop falling due to the strong jobs market and rapidly rising public sector demand, and called for spending restraint across all tiers of government. Releasing a health check of the Australian economy on Tuesday, the Washington-based IMF… Read More »‘Significant risk’ Australian inflation might stop falling: IMF

S&P 500 closes higher to begin holiday week, tech stocks lead the advance: Live updates

Stocks rose on Monday to start a holiday-shortened trading week as the continuous strength in technology names helped the broader market. The S&P 500 gained 0.73% to 5,974.07. The tech-heavy Nasdaq Composite rose 0.98% to 19,764.89, as Tesla and Meta Platforms added more than 2% and Nvidia climbed more than 3%. The Dow Jones Industrial Average erased earlier losses and ended the… Read More »S&P 500 closes higher to begin holiday week, tech stocks lead the advance: Live updates

Behind Amazon’s quiet launch of Haul, which competes with Temu in ultra-low-price items from China

Two weeks before Black Friday, Amazon quietly added a new section to the top of its mobile app. Called Haul, it’s a mobile-only area for ultra-low-price items, primarily shipped directly from China.   Haul is Amazon’s answer to the booming popularity of apps such as PDD Holdings’ Temu and fast-fashion retailer Shein. Amazon told… Read More »Behind Amazon’s quiet launch of Haul, which competes with Temu in ultra-low-price items from China

The stocks that did the most damage in 2024 – and the ones that ruled

Australian shares smashed records in 2024 but the benchmark S&P/ASX 200 Index will finish the year with only a 6 per cent advance to show for it because for every Commonwealth Bank millionaire, there were plenty of lithium, casino and fast food land mines to humble the wisest investors. Banking… Read More »The stocks that did the most damage in 2024 – and the ones that ruled

ESG investing on shaky footing as green fatigue sweeps ETF market

Funds prioritising environmental, social and governance concerns face their biggest test as investors lose interest, triggering a wave of closures. Australian investors allocated $800 million into ESG exchange-traded funds over the past year, representing just 3 per cent of all new money going into ETFs, according to figures compiled by… Read More »ESG investing on shaky footing as green fatigue sweeps ETF market

ASX says it will trade as normal on Monday, narrowly avoiding disaster

The ASX has narrowly avoided the need to delay or cancel trading on Monday after engineers working through the weekend to resolve serious issues with its critical settlements processing system. The faults were discovered on Friday and meant that trades made earlier in the week could not be settled, leaving… Read More »ASX says it will trade as normal on Monday, narrowly avoiding disaster

Bull market tested as volatility spikes, overheated assets cool off. The testing may not be done

A turbulent week on Wall Street ends with a “Thank Goolsbee, it’s Friday” rally, after the Chicago Fed President used a CNBC appearance to refocus investors’ attention on the still-encouraging trend in inflation and the likelihood that interest rates still have room to be trimmed in the context of a healthy economy.… Read More »Bull market tested as volatility spikes, overheated assets cool off. The testing may not be done

FDA says Eli Lilly’s weight loss drug Zepbound is no longer in shortage

 Points The Food and Drug Administration on Thursday said the active ingredient in Eli Lilly’s weight loss drug Zepbound is no longer in shortage, a decision that will eventually bar compounding pharmacies from making cheaper, unbranded versions of the injection. “FDA has determined that the shortage of tirzepatide injection products, which first began… Read More »FDA says Eli Lilly’s weight loss drug Zepbound is no longer in shortage